期刊文献+

酪氨酸羟化酶重组腺病毒在293细胞中的表达及体外活性测定 被引量:3

Recombinant adenovirus-mediated expression of tyrosine hydroxylase in 293 cells and activity assay of the expressed protein in vitro by capillary electrophoresis
下载PDF
导出
摘要 目的构建一种能够携带酪氨酸羟化酶(TH)进入帕金森氏病动物模型体内的重组腺病毒,该病毒能够使TH基因转录并且能够翻译成具有活性的功能蛋白。方法将TH基因插入穿梭质粒,重组穿梭质粒与腺病毒基因组在BJ-5183中进行同源重组,将重组成功的腺病毒基因组转染293细胞,使其在293细胞中包装出重组腺病毒,RT-PCR和免疫荧光检测目的基因的转录和表达。利用毛细管电泳法检测L-DOPA的生成。结果成功构建能够表达TH基因的重组腺病毒,RT-PCR能够扩增目的插入片段,毛细管电泳能够检测到L-DOPA的生成。结论该重组腺病毒能够在体外很好地表达具有活性的酪氨酸羟化酶,为利用该基因对帕金森氏病动物模型进行基因治疗打下基础。 Objective To construct a recombinant adenovirus for carry tyrosine hydroxylase (TH) gene and expressing bioactive TH protein in the animal model of Parkinson disease.Methods The TH gene was inserted into the shuttle plasmid,which was transformed into E.coli BJ-5183 for homologous recombination with the adenovirus genome.293 cells were transfected with the recombinant adenovirus genome to obtain the recombinant virus,and the transcription and expression of TH were determined by RT-PCR and immunofluorescence assay,respectively.The production of L-DOPA in the in vitro reaction system was determined using capillary electrophoresis.Results We have successfully constructed the recombinant adenovirus.The TH mRNA and the corresponding protein were detected by RT-PCR and immunofluoresence assay in 293 cells.L-DOPA was also detected in the reaction system.Conclusion The adenovirus constructed allows efficient expression of bioactive TH protein in vitro,which provides a basis for future study of gene therapy of Parkinson disease in animal models.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2010年第4期681-685,共5页 Journal of Southern Medical University
基金 国家自然科学基金(30971003)
关键词 酪氨酸羟化酶 重组腺病毒 帕金森病 毛细管电泳 tyrosine hydroxylase recombinant adenovirus Parkinson disease capillary electrophoresis
  • 相关文献

参考文献8

  • 1Nagatsu T, Levitt M, Udenfriend S. Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis [J ]. J Biochem, 1964, 239 (9): 2910-17.
  • 2Eberhardt O, Schulz JB. Gene therapy in Parkinson's disease [J]. Cell Tissue Res, 2004, 318(1): 243-60.
  • 3Mandel RJ, Rendahl KG, Spmtt SK, et al. Characterization of intrastriatal recombinant adeno-associated vires-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase Ⅰ in a rat model of Parkinson's disease [J]. J Neuroseience, 1998, 18(11): 4271-84.
  • 4Olga C, Amelia SC, Phillippe C, et al. Long-term doxycyclinecontrolled expression of human tyrosine hydroxylase atter direct adenovirus-mediated gene transfer to a rat model of Parkinson's diease[J]. PNAS, 1999,96(21): 12120-25.
  • 5Nagatsu T. Tyrosine hydroxylase: human isoforms, structure and regulation in physiology and pathology[J]. Essays Biochem, 1995, 30: 15-35.
  • 6Nasrin S, Ichinose H, Hidaka H, et al. Recombinant human tyrosine hydroxylase types 1-4 show regulatory properties for the natural (6R)-tetrahydrobiopterin cofactor[J]. J Biochcm, 1994, 116 (2): 393-8.
  • 7Edward I G, Moshe R, Brian M, et al. Expression of human tyrosine hydroxylase cDNA in invertebrate cells using a baculovirus vector [J]. J Bio Chem, 1988, 263(15): 7406-410.
  • 8杨小军,丁永辉.毛细管电泳测定血清中左旋多巴的含量[J].中国药品标准,2004,5(4):31-33. 被引量:1

二级参考文献5

  • 1[1]R.L.Falck.Carbididopa and levodopa an evalution[J].Drug Lutelligenee and Clinical Pharmacy.1976,10:84
  • 2[4]S.Vickers,E.K Stuart,Spectrofluorometic determination of carbidopa [L-(-) hydrazine-3,4-dihydroxy-methylhy ddrocinonamicacid]in plasma[J].J Pharmaceutical Sciences, 1973,62:1550
  • 3[5]S.Vickers,E.K.Stuart,H.Bhucker,et al.Further studies on the metabolism of carbidopa (-) - L-Hydrazine-3,4-dihydroxy-methyl benzenepropanoic acid monohydrate in the human,rhesus monkey, dog and rat [J].Medicinal Chemistry,1975,18(2): 134
  • 4[6]J.M.Cedarbaum, R.Williamson, H.K.utt.Simultaneous deterination of levodopa,its metabolites and carobidopa in clinical [J].J Chromatography, 1987,415: 393
  • 5孙斌,王秀梅,罗毅.硫丙麦角林在治疗帕金森病中的疗效与安全性[J].解放军保健医学杂志,2002,4(3):148-150. 被引量:2

同被引文献16

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部